Use of Pregabalin Gel on Dentin Hypersensitivity: A Randomized Clinical Trial
Operative Dentistry · 2026-03 · 51 (2) · 123-134
DOI: 10.2341/24-145-c ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Operative Dentistry, 2026-03. Verfasst von YFO Paes und 7 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben.
Abstract (Originalsprache)
Pregabalin is effective in managing various types of neural disorders due to its ability to reduce neuronal excitability. A topical pregabalin formulation may represent a promising strategy for controlling dentin hypersensitivity pain by modulating peripheral nerve fiber responses.
Objective
This randomized, double-blind, placebo-controlled clinical study aimed to evaluate the effect of an experimental gel formulation with 10% pregabalin on the control of dentin hypersensitivity (DH) and its impact on participants’ oral health-related quality of life. Methods and Materials: Sixty-four teeth (from 17 participants) were randomly assigned to the following groups: placebo gel group (Negative Control, n = 21), potassium nitrate gel group (Positive Control, n = 20) and pregabalin gel group (Pregabalin, n = 23). The impact on oral health-related quality of life was evaluated using the Dentin Hypersensitivity Experience Questionnaire (DHEQ-15) at baseline and at the final hypersensitivity recording. DH was assessed using a visual analog scale (VAS) after evaporative and tactile stimuli. Three desensitizing treatment sessions were carried out 72 hours apart, and two follow-up sessions were held at seven and 30 days after the end of treatment. The data were submitted to statistical analysis for non-parametric data. Friedman's ANOVA was followed by the Kruskal-Wallis and post hoc Dwass-Steel-Critchlow-Fligner (DSCF) pairwise comparisons. Wilcoxon and Mann-Whitney tests were used to analyze the impact on the oral health-related quality of life. All analyses adopted a 5% significance level.
Results
All groups showed a significant reduction in DH ( p < 0.05), with Positive Control and Pregabalin differing statistically from Negative Control Group only by evaporative stimuli ( p < 0.05). After 30 days of treatment, all groups showed a positive impact on oral health-related quality of life ( p < 0.001).
Conclusion
The 10% pregabalin gel was effective in reducing DH for 30 days and had a positive impact on the participants’ oral health-related quality of life.
Zitieren
APA
Paes, Y., Xavier, G., Feitosa, F., Cancian, J., Quaresma, J., Oliveira, M. D., CM, S., & Araújo, J. (2026). Use of Pregabalin Gel on Dentin Hypersensitivity: A Randomized Clinical Trial. Operative Dentistry, 51(2), 123-134. https://doi.org/10.2341/24-145-c
Vancouver
Paes Y, Xavier G, Feitosa F, Cancian J, Quaresma J, Oliveira MD, et al. Use of Pregabalin Gel on Dentin Hypersensitivity: A Randomized Clinical Trial. Operative Dentistry. 2026;51(2):123-134. doi:10.2341/24-145-c
BibTeX
@article{Paes2026,
author = {Paes, YFO and Xavier, GMB and Feitosa, FCS and Cancian, JH and Quaresma, JJ and Oliveira, MR de and CM, Silva and Araújo, JLN},
title = {Use of Pregabalin Gel on Dentin Hypersensitivity: A Randomized Clinical Trial},
journal = {Operative Dentistry},
year = {2026},
volume = {51},
number = {2},
pages = {123--134},
doi = {10.2341/24-145-c}
}
EUVIMED